INS and obesity disorder: In the liver, PDGF-AA/PDGFRα signaling integrates matrix remodeling with hepatocyte insulin action; its upregulation in obesity is associated with inflammatory tension and fibrosis, providing a non-cell-autonomous cue that exacerbates hepatic insulin resistance.